Neomycin and Polymyxin B Sulfates and Hydrocortisone (Blenheim Pharmacal, Inc)
Welcome to the PulseAid listing for the Neomycin and Polymyxin B Sulfates and Hydrocortisone drug offered from Blenheim Pharmacal, Inc. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Blenheim Pharmacal, Inc |
NON-PROPRIETARY NAME: | Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone |
SUBSTANCE NAME: | NEOMYCIN SULFATE; POLYMYXIN B SULFATE; HYDROCORTISONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | AURICULAR (OTIC) |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-05-21 |
END MARKETING DATE: | 0000-00-00 |
Neomycin and Polymyxin B Sulfates and Hydrocortisone HUMAN PRESCRIPTION DRUG Details:
Item Description | Neomycin and Polymyxin B Sulfates and Hydrocortisone from Blenheim Pharmacal, Inc |
LABELER NAME: | Blenheim Pharmacal, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.5; 10000; 10(mg/mL; [USP’U]/mL; mg/mL) |
START MARKETING DATE: | 2015-05-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10544-912_169e4bef-3d2b-3be7-e054-00144ff88e88 |
PRODUCT NDC: | 10544-912 |
APPLICATION NUMBER: | ANDA064053 |
Other NEOMYCIN SULFATE; POLYMYXIN B SULFATE; HYDROCORTISONE Pharmaceutical Manufacturers / Labelers: